Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease
NCT00002145
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
145
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Gastrointestinal Diseases
Interventions
DRUG:
Foscarnet sodium
Sponsor
Astra USA